2015年

Keystone Symposia（Mitochondria, Metabolism and Heart Failure joint with Diabetes and Metabolic Dysfunction）, January 27-February 1, Santa Fe, USA

1. Kuwabara Y. MicroRNA-451 Exacerbates Lipotoxicity in Cardiomyocytes and High-Fat Diet-Induced Cardiac Hypertrophy in Mice through Suppression of the LKB1/AMPK Pathway.

American College of Cardiology 2015. 64th Annual Scientific Session & Expo（ACC）, March 14-17, San Diego, USA 

1. Shiomi H. Value of QRS Score at Presentation in Predicting Infarct Size and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
2. Toyota T, Shiomi H, Morimoto T, Kimura T, Long-term Clinical Outcomes With Everolimus-eluting Stents and Sirolimus-eluting Stents. an Updated Meta-analysis of Randomized Controlled Trials.

TCTAP2015, April 28-May 1, Seoul Korea

1. Kimura T. Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center.
2. Tazaki J, Kimura T. Tips and Outcomes of Coil Embolization for Type II Endoleak After EVAR.
3. Tazaki J, Kimura T. Successful Complete Embolization for Type II Endoleak from Lumber Arteries After EVAR.

20th Asian Pacific Society of Cardiology Congress, April 29-May 2, ADNEC, Abu Dhabi, UAE

1. Kuwabara Y, Horie T, Baba O, Izuhara M, Usami S, Nakao T, Nishiga M, Nishino T, Ide Y, Nakazeki F, Koyama S, Hasegawa K, Kita T, Kimura T, Ono K. MicroRNA-451 Induced by Palmitate Aggravates Diabetic Cardiomyopathy via Suppression of the LKB1/AMPK Signaling Pathway.

ICNC 2015 Nuclear Cardiology and Cardiac CT 2015, May 3-5, Madrid, Spain

1. Okano M, Kato T. Normal Findings of Myocardial Scintigraphy in Patients over 85 Years of Age Still Predict Good Outcomes.

EuroPCR 2015, May 19-22, Paris, France

1. Watanabe H, Shiomi H, Kimura T. Clinical impact of revascularization of coronary CTO in non-infarct-related artery in patients with acute STEMI undergoing primary PCI (from the Credo-kyoto AMI registry).

American College of Sports Medicine (ACSM) 62nd Annual Meeting 2015, May 26-30, San Diego, CA, USA

1. Sato S, Kato T, Otsuki S, Tanaka S, Koshiyama H, Nohara R. Effects of High-intensity Interval Training on Cardiovascular Adaption and Mitochondrial Function in Type 2 Diabetes.

The 25th European Meeting on Hypertension and Cardiovascular Protection (European Society of Hypertension) 2015, June 12-15, Milan, Italy

1. Kuwahara K, Yamada Y, Kinoshita H, Nakagawa Y, Nakao K, Kimura T. N-type Ca2+ channels blockade restores the cardiac autonomic balance and prevents lethal arrhythmias in mice with dilated cardiomyopathy.

Basic Cardiovascular Sciences 2015, Jul 13-16, 2015, Hilton New Orleans Riverside, New Orleans, Louisiana, USA

1. Horie T, Nishino T, Kuwabara Y, Baba O, Kimura T, Ono K. Serum HDL-C decreases in microRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1).
2. Kuwabara Y, Horie T, Baba O, Kita T, Kimura T, Ono K. MicroRNA-451 Aggravates Lipotoxic Cardiomyopathy through Suppression of the LKB1/AMPK Pathway.

ESC CONGRESS 2015, August 29-September 2, London, UK

1. Kimura T. ABSORB Japan. 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions.
2. Watanabe H, Shiomi H, Kimura T. Clinical impact of chronic total occlusion in non-infarct-related artery on long-term clinical outcomes in patients with multi-vessel disease undergoing primary PCI for ST-elevation acute myocardial infarction (from the CREDO-Kyoto AMIregistry).
3. Nishiuchi S. Abnormal expressions of cardiac ion channels-associated genes in lamin A/C-related cardiomyopathy-specific induced pluripotent stem cell-derived cardiomyocytes.
4. Toyota T, Shiomi H, Morimoto T, Natsuaki M, Kimura T. Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: a comparison between the DAPT trial and 9 other trials evaluating DAPT duration.
5. Taniguchi T, Shiomi H, Kosuge M, Morimoto T, Nishiga M, Nakatsuma K, Sasa T, Saito N, Kimura T. Prognostic impact of electrocardiographic abnormalities in patients with severe aortic stenosis.
6. Nakatsuma K, Shiomi H, Morimoto T, et al. Intravascular Ultrasound Guidance versus Angiographic Guidance in Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction. Long-term Clinical Outcomes from the CREDO-Kyoto AMI Registry.
7. Okano M, Kato T, Miyata A, Nagano T, Inoko M. Factors associated with increased levels of serum cardiac troponin during the peripartum period.
8. Okano M, Kato T, Funasako M, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko M. Significance of left ventricular hypertrophy detected by electrocardiography in an era when echocardiography is widely available.
9. Okano M, Kato T, Inoko M. Determinants of electrocardiographic parameters for the left ventricular mass index on echocardiography.

CSI 2015, August 30-September 3, Frankfrut, Germany

1. Imai M, Watanabe S, Toyoda T, Kimura T. Successful Percutaneous Closure of Large and Maialigment Atrial Septal Defects with Plumonary Hypertension.

The MOJO of Muscle:Past, Present and Future, September 25-26, Dallas, TX, USA

1. Kuwahara K. Tripping out with Trpc.

1st International Symposium on Brain Protein Aging and Dementia Control, October 9-10, Nagoya

1. Ohno M, Hiraoka Y, Lichtenthaler SF, Nishi K, Saijo S, Sakamoto J, Chen P-M, Tomimoto H, Araki W, Takahashi R, Kita T, Kimura T, Nishi E. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.

TCT 2015, October 11-15, San Francisco,USA

1. Kimura T. Session IV. DES Thrombosis and Restenosis.
2. Kimura T. Plenary Session VII. First Report Investigations.
3. Kimura T. New Randomized Trial Data (1-Year Outcomes). ABSORB Japan (ESC Late-Breaking Trial Results and Beyond).
4. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Sakata R, Kimura T. CURRENT AS registry Investigators. Evaluation of Initial Surgical Versus Conservative Strategies In Patients With Asymptomatic Severe Aortic Stenosis.

The 59th Annual Scientific Meeting of the Korean Society of Cardiology (KSC2015), October 16-17, Goyang, Korea

1. Shiomi H. Primary PCI and Clinical Outcome in STEMI-Current Status in Japan from the CREDO-Kyoto AMI Registry.

Keystone Symposia, October 25-29, Kyoto

1. Nishi K, Inagaki N, Nishi E. Nardilysin is a critical regulator of glucose-stimulated insulin secretion.

Abbott Japan Evening Symposium October 13th, San Francisco, USA

1. Kimura T. ABSORB Japan and STOPDAPT -1 and -2 Trials.

Kidney Week 2015, November 3-8, San Diego, USA

1. Kitai Y, Ozasa N, Yanagita M, Kimura T. Prognostic implications of anemia in patients with chronic kidney disease undergoing elective percutaneous coronary intervention.

American Heart Association Annual Scientific Sessions 2015, November 7-11, Orlando, Florida, USA

1. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y, Koyama S, Sowa N, Nakashima Y, Hakuno D, Kimura T, Ono K. Serum HDL cholesterol decreases in microRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor1 (Srebf1).
2. Izuhara M, Ono K, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Tada T, Tazaki J, Horie T, Kuwabara Y, Baba O, Nishino T, Kita T, Kimura T. CREDO-Kyoto PCI/CABG Registry Cohort-2Investigators. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: A report from the CREDO-Kyoto registry cohort-2.
3. Yamamoto Y. Modeling of long-QT syndrome associated with a calmodulin mutation using human induced pluripotent stem cells.
4. Toyota T. Reappraisal of antithrombotic-regimen in patients with atrial fibrillation after drug-eluting stent implantation. When to skip aspirin? Look back on the case-experience.
5. Hatani T, Funakoshi S, Thomas J Deerinck, Eric A Bushong, Kimura T, Yamanaka S, Mark H Ellisman, Hoshijima M, Yoshida Y. 1064. Stably Expressed APEX2 Identifies the Integration of iPSC-derived Cardiomyocytes in a Mouse Model of Myocardial Infarction.
6. Yasuda M, Iwanaga Y, Kato T, Izumi T, Inuzuka Y, Nakamura T, Kawamura T, Ikeguchi S, Inoko M, Kurita T, Miyazaki S. Risk stratification for ventricular tachyarrhythmias in patients with cardiac sarcoidosis by cardiac magnetic resonance imaging.

8th Asia-Pacific Heart Rhythm Scientific Session, November 19-22, Melbourne, Australia

1. Makiyama T. Genetics 8: Advances in Diagnosis and Management of CPVT: Prevention of Sudden death in CPVT: who gets an ICD?
2. Makiyama T. Paeds 3 with GENETICS: Paediatric Cardiac Inherited Disease: The latest on the treatment of CPVT in children.

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.